Physician

Ariadne Vogel Ebel, D.O,

According to 2025 Medicare claims, Ariadne Ebel, D.O, (NPI: 1912391962) practices rheumatology in the Fort Collins-Loveland, CO market, with the plurality of this provider's patient population coming from Larimer, CO. This provider's primary affiliated billing organization is POUDRE VALLEY MEDICAL GROUP, LLC (NPI: 1366763260; TIN: 800348943) and primary practice location at 80538-9004. Ebel is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Banner Network Colorado, LLC (ACO ID: A4768), Caravan Health ACO 50 LLC (ACO ID: A5160), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Ebel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 305 traditional Medicare patients, billed 42,315 HCPCS/CPT codes, and received $618,323 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,458 prescription claims across 285 beneficiaries totaling $1,466,228 in drug costs, led by Rinvoq (Upadacitinib). Open Payments data shows 3 records totaling $220. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $15,967 to $618,323. Similarly, Part D prescription costs have risen steadily, from $6,299 to $1,466,228. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	42	658	$15,967
2021	165	4,876	$118,224
2022	183	12,310	$263,607
2023	340	32,990	$530,515
2024	305	42,315	$618,323

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	26	100	$6,299
2016	55	212	$15,691
2017	69	272	$10,091
2018	79	296	$63,786
2019	38	195	$141,175
2020	64	255	$112,283
2021	163	631	$309,296
2022	173	870	$549,420
2023	307	1,417	$729,095
2024	285	1,458	$1,466,228

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	65	105	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	184	355	$89
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	57	113	$44
96415	Administration of chemotherapy into vein, each additional hour	47	81	$22
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	151	258	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rinvoq	Upadacitinib	43	1,470	$319,432
Humira(Cf) Pen	Adalimumab	31	852	$255,847
Cosentyx Sensoready Pen	Secukinumab	11	308	$90,893
Otezla	Apremilast	14	420	$68,084
Forteo	Teriparatide	16	458	$66,935

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$220	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ariadne Vogel Ebel, D.O, ?

Tedicare shows public-source Medicare data for Ariadne Vogel Ebel, D.O, (NPI 1912391962), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ariadne Vogel Ebel, D.O, have ACO affiliation data?

Ariadne Vogel Ebel, D.O, is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Banner Network Colorado, LLC (MSSP, ACO ID A4768), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Ariadne Vogel Ebel, D.O, ?

Ariadne Vogel Ebel, D.O, is linked to POUDRE VALLEY MEDICAL GROUP, LLC (billing NPI 1366763260) in the available physician profile data.

Does Ariadne Vogel Ebel, D.O, have Open Payments data?

Ariadne Vogel Ebel, D.O, has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.